NIH-funded research R21 grant

Mosquito immunity: uncovering how malaria-carrying mosquitoes defend themselves

Official title: Larval immunity in mosquitoes

Funded at Kansas State University · NIH-11440915 · Data updated 2026-11-12

Researchers are studying the immune system of the malaria-carrying mosquito Anopheles gambiae to understand how its body fights infections and how that might affect disease transmission.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionKansas State University
NIH-funded
Lab location1 site (Manhattan, United States)
Project startSeptember 1, 2026
Project endAugust 31, 2028
Funding year2026
Award (this year)$238,247
NIH project number1R21AI202136-01
Project IDNIH-11440915 on NIH RePORTER

Who could benefit from this research

Could help

Not applicable to patients; involves mosquito biology.

Less likely to help

No direct patient participation; the study does not involve people.

What this research studies

This project looks at the proteins and enzymes that control a key mosquito immune process called melanization, which can influence how long mosquitoes live and how often they bite. By mapping how protease cascades activate phenoloxidase, researchers aim to reveal how mosquitoes respond to bacteria, fungi, and malaria parasites. The findings could inform strategies to modify mosquito biology and reduce malaria transmission. The work will be done using mosquito samples and molecular techniques over a two-year period.

Why it matters

Potential benefit: If successful, the study could lead to new ways to reduce malaria transmission by altering mosquito immunity and biology.

How similar studies have gone: Prior research shows that manipulating mosquito immune pathways can affect vector capacity, but this project focuses on a specific proteolytic network in An. gambiae.

Where this research is happening

  • Kansas State University
    Manhattan, United States
    Active

Researchers

  • Principal investigator: Michel, Kristin — Kansas State University
  • Study coordinator: Michel, Kristin

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.